MSLPQ has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
MSLPQ has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
The historical data trend for MusclePharm's Cyclically Adjusted PB Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
MusclePharm Annual Data | |||||||||||||||||||||
Trend | Dec12 | Dec13 | Dec14 | Dec15 | Dec16 | Dec17 | Dec18 | Dec19 | Dec20 | Dec21 | |||||||||||
Cyclically Adjusted PB Ratio | Get a 7-Day Free Trial | - | - | - | - | - |
MusclePharm Quarterly Data | ||||||||||||||||||||
Jun17 | Sep17 | Dec17 | Mar18 | Jun18 | Sep18 | Dec18 | Mar19 | Jun19 | Sep19 | Dec19 | Mar20 | Jun20 | Sep20 | Dec20 | Mar21 | Jun21 | Sep21 | Dec21 | Mar22 | |
Cyclically Adjusted PB Ratio | Get a 7-Day Free Trial | - | - | - | - | - |
For the Packaged Foods subindustry, MusclePharm's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
For the Consumer Packaged Goods industry and Consumer Defensive sector, MusclePharm's Cyclically Adjusted PB Ratio distribution charts can be found below:
* The bar in red indicates where MusclePharm's Cyclically Adjusted PB Ratio falls into.
Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.
The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.
MusclePharm's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2022 is calculated as:
For example, MusclePharm's adjusted Book Value per Share data for the three months ended in Mar. 2022 was:
Adj_Book | = | Book Value per Share | / | CPI of Mar. 2022 (Change) | * | Current CPI (Mar. 2022) |
= | -1.14 | / | 121.3010 | * | 121.3010 | |
= | -1.140 |
Current CPI (Mar. 2022) = 121.3010.
MusclePharm Quarterly Data
Book Value per Share | CPI | Adj_Book | |
201206 | -6.736 | 96.819 | -8.439 |
201209 | -2.738 | 97.633 | -3.402 |
201212 | -3.552 | 96.871 | -4.448 |
201303 | 1.067 | 98.209 | 1.318 |
201306 | 1.634 | 98.518 | 2.012 |
201309 | 2.558 | 98.790 | 3.141 |
201312 | 2.171 | 98.326 | 2.678 |
201403 | 3.362 | 99.695 | 4.091 |
201406 | 3.589 | 100.560 | 4.329 |
201409 | 3.464 | 100.428 | 4.184 |
201412 | 1.782 | 99.070 | 2.182 |
201503 | 1.554 | 99.621 | 1.892 |
201506 | 1.318 | 100.684 | 1.588 |
201509 | -0.404 | 100.392 | -0.488 |
201512 | -0.730 | 99.792 | -0.887 |
201603 | -0.853 | 100.470 | -1.030 |
201606 | -1.084 | 101.688 | -1.293 |
201609 | -1.180 | 101.861 | -1.405 |
201612 | -0.346 | 101.863 | -0.412 |
201703 | -0.513 | 102.862 | -0.605 |
201706 | -0.691 | 103.349 | -0.811 |
201709 | -0.782 | 104.136 | -0.911 |
201712 | -0.856 | 104.011 | -0.998 |
201803 | -0.994 | 105.290 | -1.145 |
201806 | -1.037 | 106.317 | -1.183 |
201809 | -1.141 | 106.507 | -1.299 |
201812 | -1.841 | 105.998 | -2.107 |
201903 | -2.068 | 107.251 | -2.339 |
201906 | -2.394 | 108.070 | -2.687 |
201909 | -0.748 | 108.329 | -0.838 |
201912 | -0.847 | 108.420 | -0.948 |
202003 | -0.842 | 108.902 | -0.938 |
202006 | -0.844 | 108.767 | -0.941 |
202009 | -0.823 | 109.815 | -0.909 |
202012 | -0.738 | 109.897 | -0.815 |
202103 | -0.729 | 111.754 | -0.791 |
202106 | -0.787 | 114.631 | -0.833 |
202109 | -0.893 | 115.734 | -0.936 |
202112 | -0.964 | 117.630 | -0.994 |
202203 | -1.140 | 121.301 | -1.140 |
Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.
Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.
MusclePharm (OTCPK:MSLPQ) Cyclically Adjusted PB Ratio Explanation
Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.
If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.
Thank you for viewing the detailed overview of MusclePharm's Cyclically Adjusted PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.
Eric Chin | officer: Chief Accounting Officer | 1668 S. GARFIELD AVE., 2ND FLOOR, ALHAMBRA CA 91801 |
Paul W Karr | director | BRISTOL MEYERS SQUIBB CO, 345 PARK AVENUE, NEW YORK NY 10154 |
Sabina Rizvi | officer: President & CFO | 6728 W. SUNSET ROAD, SUITE 130, LAS VEGAS NV 89118 |
Michael David Heller | director | 4500 PARK GRANADA, SUITE 202, CALABASAS CA 91302 |
Wynnefield Partners Small Cap Value Lp I | 10 percent owner | 450 SEVENTH AVENUE, SUITE 509, NEW YORK NY 10123 |
Donald Feagan | 10 percent owner | 2150 SOUTH 1300 EAST STREET, SUITE 500, SALT LAKE CITY UT 84106 |
Amerop Holdings, Inc. | 10 percent owner | 1800 BROADWAY, SUITE 100, BOULDER CO 80302 |
White Winston Select Asset Fund Series Fund Mp-18, Llc | 10 percent owner | C/O WHITE WINSTON SELECT ASSET FUNDS, LLC, 265 FRANKLIN ST., SUITE 1702, BOSTON MA 02110 |
Robert P Mahoney | 10 percent owner | 4 DANIELS FARM ROAD, #305, TRUMBULL CT 06611 |
White Winston Select Asset Funds, Llc | 10 percent owner | 265 FRANKLIN STREET, SUITE 1702, BOSTON MA 02110 |
Todd M. Enright | 10 percent owner | 2150 SOUTH 1300 EAST STREET, SUITE 500, SALT LAKE CITY UT 84106 |
Mark Blundell | 10 percent owner | 8 MACDONALD AVE, ARMOUK NY 10504 |
John J Desmond | director | 10 GLEN HEAD ROAD, GLEN HEAD NY 11545 |
Wynnefield Small Cap Value Offshore Fund Ltd | 10 percent owner | 450 SEVENTH AVE, STE 509, NEW YORK NY 10123 |
Wynnefield Capital Inc | 10 percent owner | 450 SEVENTH AVE, STE 509, NEW YORK NY 10123 |
From GuruFocus
By Marketwired Marketwired • 10-29-2021
By Marketwired Marketwired • 01-21-2021
By GuruFocusNews GuruFocusNews • 03-31-2022
By Marketwired Marketwired • 01-06-2021
By GuruFocusNews GuruFocusNews • 02-07-2022
By GuruFocusNews GuruFocusNews • 04-12-2022
By GuruFocusNews GuruFocusNews • 02-15-2022
By Marketwired Marketwired • 12-07-2020
By GuruFocusNews GuruFocusNews • 02-24-2022
By GuruFocusNews GuruFocusNews • 02-02-2022
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.